| Nov 8 |
InMed announces share consolidation to satisfy Nasdaq listing rules
|
| Nov 8 |
InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules
|
| Nov 5 |
InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules
|
| Oct 28 |
InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer's Disease
|
| Aug 21 |
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
|
| Aug 20 |
InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday
|
| Aug 20 |
InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer's Disease
|
| Jul 30 |
InMed Pharmaceuticals Announces Favorable Behavioral Outcomes with INM-901 in Long-Term Preclinical Alzheimer's Disease Study, Confirming Previous Short-Term Pilot Study Data
|
| Jun 10 |
InMed to Present at the Emerging Growth Conference
|
| Jun 6 |
Why Smartsheet Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
|
